PABPC4, another associated protein of Lnc-PCIR, which has been demonstrated related to the inflammatory biomarker (C-reactive protein) and anti-hepatitis C response, is expressed at a higher level in tumor tissues (34, 35). This evidence concerns the gene CRP and hepatitis C virus infection.